Latinib 250 mg (Lapatinib), general Tykerb is a traditional drug used to treat mortal epidermal growth factor receptor type 2 (HER2) positive advanced or metastatic bone cancer that has spread to another corridor of the body and who have formerly been treated with other chemotherapy specifics including an anthracycline, taxane, and trastuzumab (Herceptin). Lapatinib is manufactured by Drug International Ltd. in Bangladesh.
Have to take it orally formerly daily on an empty stomach at least 1 hour before or 1 hour after a mess.
The most common adverse responses are
Nausea, puking, worried stomach, mouth blisters, mild rash, dry skin, and trouble sleeping.
The below information comes from the Internet. Please consult with the croaker for medical advice.
* Any advice on the use of the medicine is for reference only. Please consult with a croaker for medical advice. All Names, ensigns, and trademarks are the property of their separate possessors. Watermarks and QR canons are used for identification purposes only.